Aug. 9 - This is the second in a two-part series about the international organ black market and how bad actors are using different means to buy and sell body parts. An organ black market thrives in certain regions based on skirted laws, bad actors and an unethical approach to broader organ transplantation—and law enforcement collaboration at the international level is the only way to curb it, experts have told Newsweek.

Aug. 7 - The grant awarded to Dr. Jelena M. Janjic of Duquesne’s School of Pharmacy will create novel preservation strategies for multiple tissue types, including skin, bone, nerves and blood vessels. Preserving tissue is essential for successful transplantation, as several hours can pass before the donor tissue is recovered and transplanted into the patient. As the lead researcher, Dr. Janjic will partner with Dr. Vijay S. Gorantla, professor of surgery at Atrium Health Wake Forest Baptist Medical Center, to study the efficacy of novel therapies developed in her lab at Duquesne. Faron Pharmaceuticals, a Finnish drug discovery company, and BMIOrganbank, a leader in clinical and research solutions for organ preservation, are industry collaborators on the project.

Aug. 9 - A new study from UC Davis Health could help to increase the supply of donor kidneys. Researchers have found that transplant patients who receive kidneys infected with the parasite toxoplasma have virtually the same outcomes as those who receive toxoplasma-negative organs.

Aug. 1 - parities in timely wait-listing among pediatric kidney transplant candidates expose some patients to greater harms from dialysis, according to a study published online Aug. 1 in Pediatrics. The researchers found that female sex, Hispanic ethnicity, Black race, and public insurance were associated with a lower adjusted relative risk for preemptive wait-listing (that is, wait-list addition before receiving dialysis), which was not associated with time from wait-list activation to transplantation (adjusted hazard ratio 0.94; 95 percent confidence interval, 0.87 to 1.02).

Aug. 1 - Certain patients with colorectal cancer that has metastasized to the liver may experience improved progression-free survival with liver transplantation compared with standard therapies, according to a recent study published by Byrne et al in JAMA Surgery.

July 30 - Lung diseases kill millions of people around the world each year. Treatment options are limited, and animal models for studying these illnesses and experimental medications are inadequate. Now, researchers describe their success in creating a mucus-based bioink for 3D printing lung tissue. This advance could one day help study and treat chronic lung conditions.